Difference between revisions of "Talk:ABCC2"

Talk:ABCC2 (view source)

127 bytes added , Tuesday at 01:16

no edit summary

49,277

edits

Revision as of 00:30, 19 May 2026 (view source) Michael (talk \| contribs) (→‎Abstract: new section)		Latest revision as of 01:16, 19 May 2026 (view source) Michael (talk \| contribs)
Line 1:		Line 1:
	== Abstract ==		== Abstract ==

	''Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition~~'' - CKCis 2026~~		Castillo VF, Yacoub JM, Cornacchia K, Patel S, Mimosa M, Zakhary A, van der Kwast T, Trpkov K, Saleeb R, 2026, "Papillary renal cell carcinoma with ABCC2 brush border immunoreactivity confers resistance to cabozantinib, highlighting the therapeutic potential of ABCC2 inhibition", Canadian Kidney Cancer Forum.